威尔药业 (603351.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(威尔药业)

导出到EXCEL
报表范围选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2018年三季报2018年中报2017年年报2017年三季报2017年中报
上市前/上市后 上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 599,908,138.09407,453,253.43694,110,645.43515,127,106.28330,990,192.56
 营业收入(元) 599,908,138.09407,453,253.43694,110,645.43515,127,106.28330,990,192.56
二、营业总成本(元) 505,765,081.21339,176,372.05573,556,577.79420,384,353.17261,707,297.55
 营业成本(元) 412,402,336.73277,422,883.30451,619,150.47333,390,382.69207,991,792.08
 营业税金及附加(元) 4,401,491.092,763,723.565,869,847.914,526,945.842,376,315.55
 销售费用(元) 21,900,801.6914,278,773.2628,305,426.5120,782,850.0613,689,577.68
 管理费用(元) 61,866,375.2039,743,501.9382,526,775.7757,784,214.9035,076,412.63
 财务费用(元) 4,735,494.913,682,804.345,268,809.343,023,192.871,927,222.54
 资产减值损失(元) 458,581.591,284,685.66-33,432.21876,766.81645,977.07
 加:投资收益(元) --38,282.8038,282.8038,282.80
四、营业利润(元) 99,147,591.0571,849,712.46125,900,633.1397,606,887.5869,321,177.81
 加:营业外收入(元) ----1,590,454.55
 减:营业外支出(元) 330,712.2627,439.63222,264.89112,253.0476,561.17
  其中:非流动资产处置净损失(元) ----8,974.97
五、利润总额(元) 98,816,878.7971,822,272.83125,678,368.2497,494,634.5470,835,071.19
 减:所得税费用(元) 14,715,321.6110,668,826.2718,242,938.9714,861,939.3610,343,168.68
六、净利润(元) 84,101,557.1861,153,446.56107,435,429.2782,632,695.1860,491,902.51
 归属于母公司股东的净利润(元) 84,101,557.1861,153,446.56107,432,216.4982,629,482.4060,493,674.11
 少数股东损益(元) --3,212.783,212.78-1,771.60
 扣除非经常性损益后的净利润(元) 79,541,200.0057,790,500.00102,929,400.0080,184,200.0059,026,900.00
七、每股收益
 一、基本每股收益(元) 1.681.222.151.651.21
 二、稀释每股收益(元) 1.681.222.151.651.21
九、综合收益总额(元) 84,101,557.1861,153,446.56107,435,429.2782,632,695.1860,491,902.51
 归属于母公司所有者的综合收益总额(元) 84,101,557.1861,153,446.56107,432,216.4982,629,482.4060,493,674.11
 归属于少数股东的综合收益总额(元) --3,212.783,212.78-1,771.60
公告日期 2019-01-142019-01-142018-04-272019-01-142017-11-24
审计意见(境内) 未经审计标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

IPO咨询服务